S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

HCM HUTCHMED China Limited

21.75

0.93 (4.47%)

11 May 2024 - Closed

Delayed by 15 minutes

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

0001104659-24-028454.txt

HUTCHMED China (NASDAQ:HCM)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more HUTCHMED China Charts.

HUTCHMED China (NASDAQ:HCM)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more HUTCHMED China Charts.

HUTCHMED China Limited News

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Wednesday 8 May 2024 (4 days ago) • GlobeNewswire Inc.

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
Friday 26 April 2024 (2 weeks ago) • GlobeNewswire Inc.

HUTCHMED Highlights Data to be Presented at AACR Congress 2024
Friday 5 April 2024 (1 month ago) • GlobeNewswire Inc.

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
Friday 22 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session
Wednesday 7 February 2024 (3 months ago) • GlobeNewswire Inc.

More HUTCHMED China Limited News Articles

Australian SE All Ordina...

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions